• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌和结直肠癌患者的血清孕酮水平。

Serum progesterone levels in patients with gastric and colorectal cancers.

作者信息

Kuru B, Ozaslan C, Yalman K, Camlýbel M

机构信息

Department of General Surgery, Ankara Oncology Education and Research Hospital, Ankara, Turkey.

出版信息

Acta Chir Belg. 2002 Apr;102(2):122-5. doi: 10.1080/00015458.2002.11679278.

DOI:10.1080/00015458.2002.11679278
PMID:12051085
Abstract

BACKGROUND

It is known that various malignant tissues possess progesterone receptors. It has been reported that the serum progesterone levels increase and show a prognostic significance in gastric carcinoma. We carried out a study to determine the serum progesterone level in gastric cancer, and colorectal cancer.

METHODS

140 of our patients were male and 56 female. We determined serum progesterone level in patients with gastric cancer, and colorectal cancer. Patients with benign diseases participated in the study as control group.

RESULTS

In male patients with gastric cancer (n = 90) and colorectal cancer (n = 50) the serum progesterone level was not significantly higher than in the control group (n = 80) (mean: 1.08 +/- 0.73, 1.08 +/- 0.32 and 1.01 +/- 0.38 ng/ml, respectively). Among the female patients with gastric cancer (n = 26) and colorectal cancer (n = 30), the serum progesterone level was also not significantly higher than in the control group (n = 30) (mean: 1.19 +/- 0.77, 1.21 +/- 0.72 and 1.12 +/- 0.61 respectively). In males, the sensitivity of progesterone for gastric cancer was 55.5% and 64% for colorectal cancer with a specificity of 37.5%. In females, the sensitivity of progesterone for gastric cancer was 54% and 57% for colorectal patients with a specificity of 40%.

CONCLUSIONS

Serum progesterone level does not correlate with the presence or absence of gastric cancer or colorectal cancer, and it is not a useful tumour marker.

摘要

背景

已知多种恶性组织含有孕激素受体。据报道,血清孕激素水平在胃癌中升高并具有预后意义。我们开展了一项研究以测定胃癌和结直肠癌患者的血清孕激素水平。

方法

我们的患者中140例为男性,56例为女性。我们测定了胃癌和结直肠癌患者的血清孕激素水平。患有良性疾病的患者作为对照组参与研究。

结果

男性胃癌患者(n = 90)和结直肠癌患者(n = 50)的血清孕激素水平并不显著高于对照组(n = 80)(均值分别为:1.08 ± 0.73、1.08 ± 0.32和1.01 ± 0.38 ng/ml)。女性胃癌患者(n = 26)和结直肠癌患者(n = 30)的血清孕激素水平也不显著高于对照组(n = 30)(均值分别为:1.19 ± 0.77、1.21 ± 0.72和1.12 ± 0.61)。在男性中,孕激素对胃癌的敏感性为55.5%,对结直肠癌的敏感性为64%,特异性为37.5%。在女性中,孕激素对胃癌的敏感性为54%,对结直肠癌患者的敏感性为57%,特异性为40%。

结论

血清孕激素水平与胃癌或结直肠癌的有无无关,它不是一种有用的肿瘤标志物。

相似文献

1
Serum progesterone levels in patients with gastric and colorectal cancers.胃癌和结直肠癌患者的血清孕酮水平。
Acta Chir Belg. 2002 Apr;102(2):122-5. doi: 10.1080/00015458.2002.11679278.
2
Serum progesterone levels in patients with gastric adenocarcinoma before and after gastrectomy.胃腺癌患者胃切除术前及术后的血清孕酮水平。
Cancer. 1998 Aug 1;83(3):445-8.
3
Elevated serum synuclein-gamma in patients with gastrointestinal and esophageal carcinomas.胃肠道和食管癌患者血清中γ-突触核蛋白水平升高。
Hepatogastroenterology. 2012 Oct;59(119):2222-7. doi: 10.5754/hge12090.
4
Plasma oxypurines in gastric and colorectal cancer.胃癌和结直肠癌中的血浆氧嘌呤
Biomed Pharmacother. 1990;44(8):403-7. doi: 10.1016/0753-3322(90)90044-a.
5
Estrogen and progesterone receptors in gastric and colorectal cancer.胃癌和结直肠癌中的雌激素和孕激素受体。
Hepatogastroenterology. 1999 Nov-Dec;46(30):3155-8.
6
[Cancer procoagulant activity in cases of esophageal, stomach and colorectal cancer considering progression degree and histological type of cancer].[考虑食管癌、胃癌和结直肠癌的进展程度及组织学类型时的癌促凝活性]
Pol Merkur Lekarski. 2001 Sep;11(63):218-20.
7
Lack of prognostic significance of conventional peritoneal cytology in colorectal and gastric cancers: results of EVOCAPE 2 multicentre prospective study.常规腹膜细胞学对结直肠癌和胃癌无预后意义:EVOCAPE 2 多中心前瞻性研究结果。
Eur J Surg Oncol. 2013 Jul;39(7):707-14. doi: 10.1016/j.ejso.2013.03.021. Epub 2013 Apr 17.
8
A novel screening biomarker in gastric cancer: serum Dickkopf-1.胃癌中的一种新型筛查生物标志物:血清Dickkopf-1。
Hepatogastroenterology. 2012 Jul-Aug;59(117):1661-4. doi: 10.5754/hge11516.
9
Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer.基质金属蛋白酶在胃癌患者血浆中的临床意义
Bull Exp Biol Med. 2019 Jan;166(3):373-376. doi: 10.1007/s10517-019-04353-y. Epub 2019 Jan 9.
10
Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.通过巢式逆转录聚合酶链反应检测结直肠癌患者血源细胞中的癌胚抗原信使核糖核酸:纵向分析及其作为多种血清标志物辅助手段的潜在重要性的论证
Cancer Res. 2001 Mar 15;61(6):2523-32.

引用本文的文献

1
Cholesterol import and steroidogenesis are biosignatures for gastric cancer patient survival.胆固醇摄取和类固醇生成是胃癌患者生存的生物标志物。
Oncotarget. 2017 Jan 3;8(1):692-704. doi: 10.18632/oncotarget.13524.